Sensitization of HER-2/neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin

Oncogene

Volumn 12, Issue 3, 1996, Pages 571-576

  Zhang, Lisha ^a   Hung, Mien Chie ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Combination therapy; Emodin; HER 2 neu; Lung cancer; Tyrosine kinase

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; EMODIN; ETOPOSIDE; PROTEIN TYROSINE KINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG SENSITIZATION; ENZYME ACTIVITY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG INTERACTIONS; EMODIN; ENZYME INHIBITORS; ETOPOSIDE; GENE EXPRESSION; GENES, ERBB-2; HUMANS; LUNG NEOPLASMS; PROTEIN-TYROSINE KINASES; RECEPTOR, ERBB-2; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030067015     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Boring CC, Squires TS, Tong T and Montgomery S. (1994). CA-Cancer. J. Clin., 44, 7-27.
2. Chan TCK, Chang C-J, Koonchanok NM and Geahlen RL. (1993). Biochem. Biophys. Res. Commun., 193, 1152-1158.
3. Coussens L, Yang-Feng T-L, Liao Y-C, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J and Francke U. (1985). Science, 230, 1132-1139.
4. Hata Y, Sandler A, Loehrer PJ, Sledge GW and Weber G. (1994). Oncogene Res., 6, 19-24.
5. Hung M-C, Schechter AT, Chevray P-Y. M, Stern DF and Weinberg RA. (1986). Proc. Natl. Acad. Sci. USA, 83, 261-264,
6. Hung M-C, Yan D-H and Zhao X-Y. (1989). Proc. Natl. Acad. Sci. USA, 86, 2545-2548.
7. Jayasuriya H, Koonchnok NM, Geahlen R, McLaughlin J and Chang C-J. (1992). J. Natl. Prod., 55, 696-698.
8. Kern JA, Schwartz DA, Nordberg JE, Weiner DB, Greene MI, Torney L and Robinson RA. (1990). Cancer Res., 50, 5184-5191.
9. Kupchan SM and Karim A. (1976). L. Lloydia., 39, 223-224.
10. Minna JD, Pass H, Glatstein E. (1989). Cancer of the lung. In Devita VT, Hellmen S and Rosenberg SA. (eds.). Principles and Practice of Oncology, pp591-705. Philadelphia: JB. Lippincott.
11. Mosmann T. (1983). J. Immunol. Methods, 65, 55-63.
12. Muller WJ, Sinn E. Pateengale PK, Wallace R and Leder P. (1988). Cell, 54, 105-115.
13. Muthuswamy SK, Siegel PM, Dankort DL, Webster MA and Muller WJ. (1994). Mol. Cell. Biol., 14, 735-743.
14. Rubinstein LV, Shoemaker RH, Paull KD, Simm RM, Tosini S, Skehan P, Scadiero DA, Monks A and Boyd MR. (1990). J. Natl. Cancer Inst., 82, 1113-1120.
15. Schechter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, Greene MI and Weinberg RA. (1984). Nature, 312, 513-516.
16. Schneider PM, Hung M-C, Chiocca SM, Manning J, Zhao X, Fang K and Roth JA. (1981). Cancer Res., 49, 4968-4971.
17. Semba K, Kamata N, Toyoshima K and Yamamoto T. (1985). Proc. Natl. Acad. Sci. USA, 82, 6497-6501.
18. Silverberg E and Lubera JA. (1988). Cancer statistics. CA-Cancer J. Clin., 38, 5-22.
19. Sistonen L, Holtta E, Lehvaslaiho H, Lehtola L and Alitalo K. (1989). J. Cell. Biol., 109, 1911-1919.
20. Tsai CM, Chang KT, Peng RP, Mitsudomi T, Chen MH and Gazder AF. (1993). J. Natl. Cancer Inst., 85, 897-901.
21. Tsai CM, Yu D, Chamg KT, Wu LH, Peng RP, Ibrahim NK and Hung M-C. (1995). J. Natl. Cancer Inst., 87, 682-684.
22. Udziak RM, Schlessinger J and Ullrich A. (1987). Proc. Natl. Acad. Sci. USA, 84, 7159-7163.
23. Webb JL. (1963). Enzyme and metabolic inhibitors. Vol. 1. Academic Press; pp507-510. New York.
24. Weiner DB, Nordberg J, Robinson R, Nowell PC, Gazder A, Greene MI Williams, WV, Cohen JA and Kern JA. (1990). Cancer Res., 50, 421-425.
25. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T and Toyoshima K. (1986). Nature, 319, 230-234.
26. Yeh SF, Chou T and Liu T. (1988). Planta Med., 54, 413-414.
27. Yu D Wolf J-K, Scanlcon M, Price JE and Hung M-C. (1993). Cancer Res., 53, 891-898.
28. Yu D and Hung M-C. (1991). Oncogene, 6, 1991-1996.
29. Yu D, Wang SS, Dulski KM, Nicolson GL and Hung M-C. (1994). Cancer Res., 54, 3260-3266.
30. Zhang L-S, Chang C-J, Bacus SS and Hung M-C. (1995). Cancer Res., 55, 3890-3896.